Showing results (681-690 of 702) with videos related to

Sort By:
Pageof 71
Cancer|August 9, 2025
Outcomes of patients with newly diagnosed acute myeloid leukemia with FLT3-tyrosine kinase domain mutations: Prognostic implications of NPM1 co-mutationSankalp Arora, Wei-Ying Jen, Musa Yilmaz, et al.
Cell Metabolism|April 21, 2023
Fructose-1,6-bisphosphatase is a nonenzymatic safety valve that curtails AKT activation to prevent insulin hyperresponsivenessLi Gu, Yahui Zhu, Kosuke Watari, et al.
Frontiers in Surgery|April 29, 2026
Evaluating the impact of surgical resection on desmoid tumour growth: a retrospective analysis from the National Cancer Centre SingaporeHan Yi Lee, Siqin Zhou, Si Min Chiow, et al.
Scientific Reports|July 30, 2021
Eradicating mesothelin-positive human gastric and pancreatic tumors in xenograft models with optimized anti-mesothelin antibody-drug conjugates from synthetic antibody librariesHung-Ju Hsu, Chao-Ping Tung, Chung-Ming Yu, et al.
Clinical and Translational Gastroenterology|January 21, 2025
Clinical Trial: Precise Administration of Sucralfate Powder in Prevention of Delayed Postpolypectomy Bleeding. A Randomized Controlled TrialHsueh-Chien Chiang, Po-Jun Chen, Er-Hsiang Yang, et al.
Gastrointestinal Endoscopy|June 25, 2023
Precise application of topical tranexamic acid to enhance endoscopic hemostasis for peptic ulcer bleeding: a randomized controlled study (with video)Hsueh-Chien Chiang, Po-Jun Chen, Er-Hsiang Yang, et al.
Nuclear Medicine and Molecular Imaging|May 7, 2019
Current Status and Growth of Nuclear Theranostics in SingaporeHian Liang Huang, Aaron Kian Ti Tong, Sue Ping Thang, et al.
Blood Cancer Journal|October 6, 2025
Randomized Phase 3 study of pomalidomide cyclophosphamide dexamethasone versus pomalidomide dexamethasone in relapse or refractory myeloma: an Asian Myeloma Network study (AMN003)Jin Seok Kim, Yang Song, Wei-Ying Jen, et al.
Annals of Neurology|June 5, 2020
NOTCH2NLC GGC Repeat Expansions Are Associated with Sporadic Essential Tremor: Variable Disease Expressivity on Long-Term Follow-upAdeline S L Ng, Weng Khong Lim, Zheyu Xu, et al.
British Journal of Haematology|September 22, 2025
MECOM fusion partner and bone marrow blast percentage influence outcomes of patients with MECOM rearranged acute myeloid leukaemiaWei-Ying Jen, Guilin Tang, Eitan Kugler, et al.
Pageof 71